Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, CA 92093, USA.
School of Public Health, San Diego State University, San Diego, CA 92182, USA.
Int J Environ Res Public Health. 2024 May 8;21(5):602. doi: 10.3390/ijerph21050602.
Black sexual minority men (BSMM) continue to bear a disproportionate burden of HIV in the United States, with the highest incidence and prevalence in the southern region of the country. In Texas, BSMM living with HIV (BSMM+) have the lowest rates of viral suppression of all SMM and have lower antiretroviral treatment (ART) adherence than white and Hispanic SMM. Long-acting injectable ART (LAI-ART) can potentially overcome several barriers to daily oral ART adherence (e.g., stigma, forgetfulness, pill fatigue). However, little is known about the knowledge, willingness, barriers, and facilitators regarding LAI-ART among BSMM+. From July 2022 to September 2023, we conducted in-depth, semi-structured interviews with 27 BSMM+ from the Houston and Dallas Metropolitan Areas, Texas. Data were analyzed using a thematic analysis approach. Most men knew about LAI-ART, but their understanding varied based on their existing sources of information. Some men were enthusiastic, some were cautious, and some reported no interest in LAI-ART. Barriers to LAI-ART included a lack of public insurance coverage of LAI-ART; fear of needles and side effects; the frequency of injection visits; the requirement of viral suppression before switching from oral ART to LAI-ART; and satisfaction with oral daily ART. Motivators of LAI-ART uptake included the eliminated burden of daily pills and reduced anxiety about possibly missing doses. BSMM+ may be among those who could most benefit from LAI-ART, though more research is needed to understand which factors influence their willingness and how the barriers to LAI-ART might be addressed, particularly among diverse communities of SMM of color.
美国的黑人男同性恋者(BSMM)继续承受着不成比例的艾滋病毒负担,该国南部地区的发病率和患病率最高。在德克萨斯州,感染艾滋病毒的 BSMM(BSMM+)的病毒抑制率是所有男同性恋者中最低的,而且比白人和西班牙裔男同性恋者的抗逆转录病毒治疗(ART)依从性更低。长效注射型抗逆转录病毒治疗(LAI-ART)有可能克服每日口服 ART 依从性的几个障碍(例如,耻辱感、健忘、药物疲劳)。然而,对于 BSMM+ 而言,人们对 LAI-ART 的了解、意愿、障碍和促进因素知之甚少。从 2022 年 7 月到 2023 年 9 月,我们对来自德克萨斯州休斯顿和达拉斯大都市区的 27 名 BSMM+ 进行了深入的半结构化访谈。使用主题分析方法对数据进行了分析。大多数男性都了解 LAI-ART,但他们的理解基于他们现有的信息来源而有所不同。一些男性很热情,一些则持谨慎态度,一些则表示对 LAI-ART 不感兴趣。LAI-ART 的障碍包括缺乏 LAI-ART 的公共保险覆盖;对针头和副作用的恐惧;注射访问的频率;从口服 ART 切换到 LAI-ART 之前需要病毒抑制;以及对口服每日 ART 的满意度。接受 LAI-ART 的动机包括消除了每日服药的负担和减少了对可能漏服剂量的焦虑。BSMM+ 可能是最能从 LAI-ART 中受益的人群之一,但需要进一步研究以了解哪些因素影响他们的意愿,以及如何解决 LAI-ART 的障碍,特别是在不同的有色人种男同性恋社区中。